Onxeo Reports Publication of Final Results of DRIIV Phase 1 Dose-Escalation Study of AsiDNA™ in Advanced Solid Tumors in the British Journal of Cancer

    NEXT STORY
    Sterilization Equipment Market – Growth, Trends, and Forecast (2020-2025)
    PREV STORY
    Landmark Consensus on Treating Adult Hearing Loss with a Cochlear Implant Published by International Hearing Experts
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ZIOPHARM Announces Publication in Scientific Reports Describing Genetic Editing of Human Leukocyte Antigen in Cell Therapies to Broaden Their Human Application

    BOSTON, Feb. 23, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...

    author_avatar
    NASDAQ Market News

    Aclaris Therapeutics Initiates Phase 2 Clinical Trial of A-101 for Treatment of Common Warts

    MALVERN, Pa., Dec. 7, 2015 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS) today announced ...

    author_avatar
    NASDAQ Market News

    Psyence Group Inc Completes Reverse Takeover Transaction and Completes Non-brokered Financing

    author_avatar
    NASDAQ Market News